scholarly journals Technologies for Detection of Babesia microti: Advances and Challenges

Pathogens ◽  
2021 ◽  
Vol 10 (12) ◽  
pp. 1563
Author(s):  
Scott Meredith ◽  
Miranda Oakley ◽  
Sanjai Kumar

The biology of intraerythrocytic Babesia parasites presents unique challenges for the diagnosis of human babesiosis. Antibody-based assays are highly sensitive but fail to detect early stage Babesia infections prior to seroconversion (window period) and cannot distinguish between an active infection and a previously resolved infection. On the other hand, nucleic acid-based tests (NAT) may lack the sensitivity to detect window cases when parasite burden is below detection limits and asymptomatic low-grade infections. Recent technological advances have improved the sensitivity, specificity and high throughput of NAT and the antibody-based detection of Babesia. Some of these advances include genomics approaches for the identification of novel high-copy-number targets for NAT and immunodominant antigens for superior antigen and antibody-based assays for Babesia. Future advances would also rely on next generation sequencing and CRISPR technology to improve Babesia detection. This review article will discuss the historical perspective and current status of technologies for the detection of Babesia microti, the most common Babesia species causing human babesiosis in the United States, and their implications for early diagnosis of acute babesiosis, blood safety and surveillance studies to monitor areas of expansion and emergence and spread of Babesia species and their genetic variants in the United States and globally.

Pathogens ◽  
2021 ◽  
Vol 10 (11) ◽  
pp. 1447
Author(s):  
Abhinav Kumar ◽  
Jane O'Bryan ◽  
Peter J. Krause

Babesiosis is an emerging tick-borne disease caused by intraerythrocytic protozoa that are primarily transmitted by hard-bodied (Ixodid) ticks and rarely through blood transfusion, perinatally, and organ transplantation. More than 100 Babesia species infect a wide spectrum of wild and domestic animals worldwide and six have been identified as human pathogens. Babesia microti is the predominant species that infects humans, is found throughout the world, and causes endemic disease in the United States and China. Babesia venatorum and Babesia crassa-like agent also cause endemic disease in China. Babesia divergens is the predominant species in Europe where fulminant cases have been reported sporadically. The number of B. microti infections has been increasing globally in recent decades. In the United States, more than 2000 cases are reported each year, although the actual number is thought to be much higher. In this review of the epidemiology of human babesiosis, we discuss epidemiologic tools used to monitor disease location and frequency; demographics and modes of transmission; the location of human babesiosis; the causative Babesia species in the Americas, Europe, Asia, Africa, and Australia; the primary clinical characteristics associated with each of these infections; and the increasing global health burden of this disease.


Author(s):  
Suzanne Moshier ◽  
William O'Dell ◽  
Raychel Watkins ◽  
Aelita Pinter

In a review of the parasites of Microtus, Timm (1985) lists no protozoan endoparasites whatsoever for this genus. The role of parasitism, whether macro- or microparasites, and whether endo- or ectoparasites, in the demographic machinery of microtines is poorly understood. Timm (1985) astutely observes that one of the most challenging and fruitful directions of future research with Microtus will be the statistical quantification of the cost of parasitism. In addition, since humans in the Grand Teton National Park may encounter protozoon parasites that are potentially pathogenic to humans, it is useful to characterize the occurrence and biology of such organisms in the parko Babesia microti, a parasitic protozoon, is transmitted by a tick vector and reproduces in the erythrocytes of its mammalian host. Initially, Babesia was thought to be restricted to small mammals; however, in 1970 the first human cases were diagnosed in residents of Nantucket Island, Massachusetts (Western et al, 1970). Over 200 cases of human babesiosis have been documented worldwide. In the United States, human babesiosis is caused by B. microti. Most of these cases have occurred in the eastern United States. The earliest report of an organism that fits the description of Babesia in human erythrocytes is that of Wilson et al. (1904), who found an unknown organism in human erythrocytes while investigating the cause of Rocky Mountain Spotted fever. Documented cases of babesiosis in many areas of the United States are increasing (Steketee et al, 1985). As humans insert themselves into places where they have historically been present only occasionally, they often contract new diseases. A second protozoon parasite, Hepatozoon sp., which is widespread in small mammals in Europe, is also found in reptiles throughout the world. The record of Hepatozoon in North American small mammals is not extensive. Fewer than 10 species of mammals have been shown to harbor Hepatozoon parasites. Like Babesia, Hepatozoon is a two-host parasite. Unlike Babesia, for which the intermediate host is always a tick, the intermediate host in the Hepatozoon may be a tick, a mite, a flea, or a mosquito. The method of transmission by the vector also differs in the two parasites. Babesia is transmitted in saliva when the tick bites, whereas Hepatozoon infection requires the vertebrate host to swallow the vector. In our 1994 studies, we sought to extend knowledge of these two parasites. The specific objectives for 1994 were: to sample specific populations of M. molltanus, in which we have previously documented Hepatozoon infections, to determine whether there are differences in the infection rates at different study sites in the park; to search for the vector of Hepatozoon sp. infections in M. montanus by examining ectoparasites; to collect and rear ticks from M. montanus for use in R microti transmission studies; and to complete a comparison of the spleen histology of babesiosis in infected and uninfected laboratory animals, with inclusion of data from wild animals, as available. Our long-term objectives are to document the effects and cost of parasitism on vole populations and to determine the potential of small mammals of Grand Teton National Park to serve as reservoirs of human parasites.


2017 ◽  
Vol 55 (10) ◽  
pp. 2903-2912 ◽  
Author(s):  
Lars F. Westblade ◽  
Matthew S. Simon ◽  
Blaine A. Mathison ◽  
Laura A. Kirkman

ABSTRACT Babesia microti , a zoonotic intraerythrocytic parasite, is the primary etiological agent of human babesiosis in the United States. Human infections range from subclinical illness to severe disease resulting in death, with symptoms being related to host immune status. Despite advances in our understanding and management of B. microti , the incidence of infection in the United States has increased. Therefore, research focused on eradicating disease and optimizing clinical management is essential. Here we review this remarkable organism, with emphasis on the clinical, diagnostic, and therapeutic aspects of human disease.


2016 ◽  
Vol 82 (22) ◽  
pp. 6624-6632 ◽  
Author(s):  
Aya Zamoto-Niikura ◽  
Shigeru Morikawa ◽  
Ken-Ichi Hanaki ◽  
Patricia J. Holman ◽  
Chiaki Ishihara

ABSTRACTThe U.S. lineage, one of the major clades in theBabesia microtigroup, is known as a causal agent of human babesiosis mostly in the northeastern and upper midwestern United States. This lineage, however, also is distributed throughout the temperate zone of Eurasia with several reported human cases, although convincing evidence of the identity of the specific vector(s) in this area is lacking. Here, the goal was to demonstrate the presence of infectious parasites directly in salivary glands ofIxodes persulcatus, from which U.S. lineage genetic sequences have been detected in Asia, and to molecularly characterize the isolates. Five PCR-positive specimens were individually inoculated into hamsters, resulting in infections in four; consequently, four strains were newly established. Molecular characterization, including 18S rRNA, β-tubulin, andCCT7gene sequences, as well as Western blot analysis and indirect fluorescent antibody assay, revealed that all four strains were identical to each other and to the U.S. lineage strains isolated from rodents captured in Japan. The 18S rRNA gene sequence from the isolates was identical to those fromI. persulcatusin Russia and China, but the genetic and antigenic profiles of the Japanese parasites differ from those in the United States and Europe. Together with previous epidemiological and transmission studies, we conclude thatI. persulcatusis likely the principal vector for theB. microtiU.S. lineage in Japan and presumably in northeastern Eurasia.IMPORTANCEThe major cause of human babesiosis, the tick-borne blood parasiteBabesia microti, U.S. lineage, is widely distributed in the temperate Northern Hemisphere. However, the specific tick vector(s) remains unidentified in Eurasia, where there are people with antibodies to theB. microtiU.S. lineage and cases of human babesiosis. In this study, the first isolation ofB. microtiU.S. lineage fromIxodes persulcatusticks, a principal vector for many tick-borne diseases, is described in Japan. Limited antigenic cross-reaction was found between the Japan and United States isolates. Thus, current serological tests based on U.S. isolates may underestimateB. microtioccurrence outside the United States. This study and previous studies indicate thatI. persulcatusis part of theB. microtiU.S. lineage life cycle in Japan and, presumably, northeastern Eurasia. This report will be important for public health, especially since infection may occur through transfusion, and also to researchers in the field of parasitology.


2019 ◽  
Vol 02 (03) ◽  
Author(s):  
Sherif Aly ◽  
Allan Stolarski ◽  
Patrick O’Neal ◽  
Edward Whang ◽  
Gentian Kristo

Harmful Algae ◽  
2021 ◽  
pp. 101975
Author(s):  
Donald M. Anderson ◽  
Elizabeth Fensin ◽  
Christopher J. Gobler ◽  
Alicia E. Hoeglund ◽  
Katherine A. Hubbard ◽  
...  

2021 ◽  
pp. 135406612098342
Author(s):  
Syed Javed Maswood

Contemporary economic globalization is typically seen as a product of both trade and economic liberalization after the Second World War and of technological advances that have made it possible to overcome coordination and management of geographically dispersed production units. Trade liberalization and technological advances were certainly important variables, but I argue that it was neo-protectionist American policies of the early 1980s that provided the initial catalyst for globally networked production processes. American protectionism encouraged Japanese investment in the United States that allowed US car manufacturers to learn the essentials of network manufacturing as practiced by Japanese transplants in the United States. In the next stage of global network manufacturing, liberal trade played a much more pivotal role because the global supply chains could not obviously be maintained without liberal trade. In this paper, I also discuss the likelihood of a reversal and suggest that globalization is unlikely to reversed in a significant way. Liberal trade is essential to the integrity of global supply chain networks, but these new production processes have themselves created a firewall against future systemic protectionism.


Author(s):  
Esteban Correa-Agudelo ◽  
Tesfaye B. Mersha ◽  
Adam J. Branscum ◽  
Neil J. MacKinnon ◽  
Diego F. Cuadros

We characterized vulnerable populations located in areas at higher risk of COVID-19-related mortality and low critical healthcare capacity during the early stage of the epidemic in the United States. We analyze data obtained from a Johns Hopkins University COVID-19 database to assess the county-level spatial variation of COVID-19-related mortality risk during the early stage of the epidemic in relation to health determinants and health infrastructure. Overall, we identified highly populated and polluted areas, regional air hub areas, race minorities (non-white population), and Hispanic or Latino population with an increased risk of COVID-19-related death during the first phase of the epidemic. The 10 highest COVID-19 mortality risk areas in highly populated counties had on average a lower proportion of white population (48.0%) and higher proportions of black population (18.7%) and other races (33.3%) compared to the national averages of 83.0%, 9.1%, and 7.9%, respectively. The Hispanic and Latino population proportion was higher in these 10 counties (29.3%, compared to the national average of 9.3%). Counties with major air hubs had a 31% increase in mortality risk compared to counties with no airport connectivity. Sixty-eight percent of the counties with high COVID-19-related mortality risk also had lower critical care capacity than the national average. The disparity in health and environmental risk factors might have exacerbated the COVID-19-related mortality risk in vulnerable groups during the early stage of the epidemic.


Sign in / Sign up

Export Citation Format

Share Document